Sector Update: Biotechnology Stocks Showing The Way On NASDAQ

By
A A A

Biotech stocks are helping to lead the market recovery today, currently up on average 1.4% as a group (SPSIBI) compared to the NASDAQ (COMP) market up 1.04% at 3,810.71. Year-to-date these specialty medical stocks focusing on pioneering advances in human therapeutics are up 48.9% compared to the NASDAQ's healthy gains of 26% year-to-date.

Stocks adding to the S&P Biotechnology Select Industry Index move higher are Amgen Inc ( AMGN ) up 2% at near $114 per share; ImmunoGen, Inc ( IMGN ) up 1.4% at $17.25 per share; and Neurocrine Biosciences Inc ( NBIX ) up 1.4% at $11.48 per share.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: AMGN , IMGN , NBIX

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com